NF2:在癌症代谢重编程和瘤免疫力中被低估的参与者
Duo Xu1, Shiyuan Yin1, Yongqian Shu2
1Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
NPJ precision oncology
|June 15, 2024
概括
神经纤维素瘤2型 (NF2) 基因失活驱动瘤的发展. 这篇评论探讨了NF2的研究.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 神经纤维素瘤类型2 (NF2) 编码了默林蛋白,这是一个参与调节细胞信号通路的瘤抑制剂.
- NF2突变与各种瘤有关,包括间皮瘤,脑膜瘤和脑膜瘤.
- 在瘤发生过程中NF2的确切作用和跨癌症突变的影响仍然不完全理解.
研究的目的:
- 巩固目前关于NF2基因在癌症中的生物学作用的知识.
- 为了检查癌症代谢和瘤免疫在默林缺乏恶性瘤之间的相互作用.
- 确定NF2相关瘤的潜在治疗策略.
主要方法:
- 文献综述和对NF2现有研究的综合.
- 对研究NF2缺乏瘤的代谢和免疫特征的研究进行分析.
- 探索基因缺陷 (例如CDKN2A/B,BAP1,LATS2) 以及它们对瘤特征的影响.
主要成果:
- NF2的失活会影响多个信号通路 (Hippo,mTOR,RAS,cGAS-STING).
- 像CDKN2A/B,BAP1和LATS2这样的基因中的编码能力有助于独特的瘤表型.
- 新出现的证据强调了代谢重编程和免疫逃避在NF2相关癌症中的重要性.
结论:
- 了解NF2在瘤发生中的复杂作用对于向治疗至关重要.
- 在默林缺乏瘤中研究代谢和免疫相互作用提供了新的治疗途径.
- 这一审查为开发NF2相关癌症的创新治疗策略提供了基础.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
The Nucleolus
8.8K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.8K
Electron Transport Chain: Complex I and II
12.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.9K


